Article Versions Notes

Orcutt KD, Henry KE, Habjan C, Palmer K, Heimann J, Cupido JM, Gottumukkala V, Cissell DD, Lyon MC, Hussein AI, et al. Dosimetry of [²¹²Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free ²⁰⁸Tl on Tissue Absorbed Doses. Molecules. 2022; 27(18):5831. https://doi.org/10.3390/molecules27185831

Orcutt, Kelly D., Kelly E. Henry, Christine Habjan, Keryn Palmer, Jack Heimann, Julie M. Cupido, Vijay Gottumukkala, Derek D. Cissell, Morgan C. Lyon, Amira I. Hussein, and et al. 2022. "Dosimetry of [²¹²Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free ²⁰⁸Tl on Tissue Absorbed Doses" Molecules 27, no. 18: 5831. https://doi.org/10.3390/molecules27185831

Orcutt, K. D., Henry, K. E., Habjan, C., Palmer, K., Heimann, J., Cupido, J. M., Gottumukkala, V., Cissell, D. D., Lyon, M. C., Hussein, A. I., Liu, D., Li, M., Johnson, F. L., & Schultz, M. K. (2022). Dosimetry of [²¹²Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free ²⁰⁸Tl on Tissue Absorbed Doses. Molecules, 27(18), 5831. https://doi.org/10.3390/molecules27185831